Insignificant tumor bed effect after pretransplantation hyperthermia.

Abstract:

:Effect of pretransplantation hyperthermia of tumor bed on tumor growth was studied. Experimental tumors were isotransplants of a fibrosarcoma which arose spontaneously in C3Hf/Sed mice. The pretransplantation hyperthermia was given at 43.5 degrees fro 120 min by immersing the mouse foot into a constant temperature water bath. This treatment resulted in a similar foot reaction to a single gamma-ray dose of 3500 rads, namely, complete epilation or partial moist desquamation. The pretransplantation hyperthermia failed to retard tumor growth, while the concurrent experiment on pretransplantation irradiation demonstrated marked retardation of tumor growth. No retardation was observed when tumor cells were transplanted into the contralateral untreated feet or into the untreated skin.

journal_name

Cancer Res

journal_title

Cancer research

authors

Urano M,Cunningham M

subject

Has Abstract

pub_date

1980-01-01 00:00:00

pages

26-8

issue

1

eissn

0008-5472

issn

1538-7445

journal_volume

40

pub_type

杂志文章
  • Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice.

    abstract::Orthotopic transplantation of human tumors in nude mice reproduces the pattern of local growth and distal dissemination. The aim of our study was to determine the pattern of genetic alterations in human carcinomas of the exocrine pancreas orthotopically implanted and perpetuated in nude mice. Eight of the sixteen orth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reyes G,Villanueva A,García C,Sancho FJ,Piulats J,Lluís F,Capellá G

    更新日期:1996-12-15 00:00:00

  • Species differences in the formation of benzo(a)pyrene-DNA adducts in rodent and human endometrium.

    abstract::The formation of adducts of benzo(a)pyrene metabolites on DNA was investigated in endometrial tissue from humans, hamsters, mice, and rats. anti-Benzo(a)pyrene-7,8-diol-9,10-epoxide was the predominant adduct identified in all the species studied. The amount of (+)-anti-benzo(a)pyrene-7,8-diol-9,10-epoxide bound to DN...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kulkarni MS,Calloway K,Irigaray MF,Kaufman DG

    更新日期:1986-06-01 00:00:00

  • Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.

    abstract::Cancer is a leading cause of mortality throughout the world and new treatments are urgently needed. Recent studies suggest that bone marrow-derived mesenchymal stem cells (MSC) home to and incorporate within tumor tissue. We hypothesized that MSCs engineered to produce and deliver tumor necrosis factor-related apoptos...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4698

    authors: Loebinger MR,Eddaoudi A,Davies D,Janes SM

    更新日期:2009-05-15 00:00:00

  • Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: implications in breast cancer.

    abstract::High amounts of nitric oxide (NO) produced by activated macrophages or NO donors are required to induce cytotoxicity and apoptosis in pathogens and tumor cells. High concentrations of NO may lead to nonspecific toxicity thereby limiting the use of NO donors in the treatment of cancer. In this study, we tested the poss...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pervin S,Singh R,Gau CL,Edamatsu H,Tamanoi F,Chaudhuri G

    更新日期:2001-06-15 00:00:00

  • Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

    abstract::In most patients with chronic myeloid leukemia (CML), the disease can be kept under control using the BCR/ABL kinase inhibitor imatinib. Nevertheless, resistance or intolerance to imatinib and other BCR/ABL inhibitors may occur during therapy. Therefore, CML research is focusing on novel targets and targeted drugs. Po...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2181

    authors: Gleixner KV,Ferenc V,Peter B,Gruze A,Meyer RA,Hadzijusufovic E,Cerny-Reiterer S,Mayerhofer M,Pickl WF,Sillaber C,Valent P

    更新日期:2010-02-15 00:00:00

  • Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma Progression.

    abstract::Deleted in colorectal cancer (DCC), the receptor for the multifunctional cue netrin-1, acts as a tumor suppressor in intestinal cancer and lung metastasis by triggering cancer cell death when netrin-1 is lowly expressed. Recent genomic data highlighted that DCC is the third most frequently mutated gene in melanoma; we...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1590

    authors: Boussouar A,Tortereau A,Manceau A,Paradisi A,Gadot N,Vial J,Neves D,Larue L,Battistella M,Leboeuf C,Lebbé C,Janin A,Mehlen P

    更新日期:2020-02-15 00:00:00

  • Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.

    abstract::TP53 is the most frequently altered gene in head and neck squamous cell carcinoma (HNSCC), with mutations occurring in over two thirds of cases; however, the predictive response of these mutations to cisplatin-based therapy remains elusive. In the current study, we evaluate the ability of the Evolutionary Action score...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2729

    authors: Osman AA,Neskey DM,Katsonis P,Patel AA,Ward AM,Hsu TK,Hicks SC,McDonald TO,Ow TJ,Alves MO,Pickering CR,Skinner HD,Zhao M,Sturgis EM,Kies MS,El-Naggar A,Perrone F,Licitra L,Bossi P,Kimmel M,Frederick MJ,Lichtarge

    更新日期:2015-04-01 00:00:00

  • Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.

    abstract::Hepatocellular carcinoma is among the most common and lethal cancers in humans. Hepatocellular carcinoma is commonly associated with physical or functional inactivation of the p53 tumor suppressor, high levels of chromosomal instability, and disease conditions causing chronic cycles of hepatocyte death and regeneratio...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4608

    authors: Farazi PA,Glickman J,Horner J,Depinho RA

    更新日期:2006-05-01 00:00:00

  • Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.

    abstract::For many solid tumors, surgical resection remains the gold standard and tumor-involved margins are associated with poor clinical outcomes. Near-infrared (NIR) fluorescence imaging using molecular agents has shown promise for in situ imaging during resection. However, for cancers with difficult imaging conditions, surg...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-0878

    authors: Gao RW,Teraphongphom NT,van den Berg NS,Martin BA,Oberhelman NJ,Divi V,Kaplan MJ,Hong SS,Lu G,Ertsey R,Tummers WSFJ,Gomez AJ,Holsinger FC,Kong CS,Colevas AD,Warram JM,Rosenthal EL

    更新日期:2018-09-01 00:00:00

  • p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.

    abstract::While the therapeutic activity of the deoxycytidine analogue decitabine is thought to reflect its ability to reactivate methylation-silenced genes, this agent is also known to trigger p53-dependent DNA damage responses. Here, we report that p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a robust transcription...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1860

    authors: Link PA,Baer MR,James SR,Jones DA,Karpf AR

    更新日期:2008-11-15 00:00:00

  • A cytokinetic analysis of bacillus calmette-guérin-induced growth control of a murine leukemia.

    abstract::The cytokinetics of an isogeneic, transplantable, lymphoid leukemia, growing as an ascitic tumor in the C57BL/6 mouse, has been investigated during normal growth and during regression induced by weekly injections i.v. of 1.0 mg Bacillus Calmette-Guérin (BCG). Survival was significantly prolonged in the BCG-treated gro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Olsson L,Mathé G

    更新日期:1977-06-01 00:00:00

  • 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.

    abstract::To assess the in vivo behavior of cytotoxic agents linked to antibodies, deferoxamine, known to form stable chelates with 67Ga, was conjugated with monoclonal antibodies using three different methods. One method used a homocoupling reagent, glutaraldehyde, whereas two other methods used heterocoupling reagents, N-succ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Koizumi M,Endo K,Kunimatsu M,Sakahara H,Nakashima T,Kawamura Y,Watanabe Y,Saga T,Konishi J,Yamamuro T

    更新日期:1988-03-01 00:00:00

  • Differential regulation of cancer progression by CDK4/6 plays a central role in DNA replication and repair pathways.

    abstract::Although the cyclin-dependent kinases CDK4 and CDK6 play fundamental roles in cancer, the specific pathways and downstream targets by which they exert their tumorigenic effects remain elusive. In this study, we uncover distinct and novel functions for these kinases in regulating tumor formation and metastatic coloniza...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-2121

    authors: Dai M,Boudreault J,Wang N,Poulet S,Daliah G,Yan G,Moamer A,Burgos SA,Sabri S,Ali S,Lebrun JJ

    更新日期:2020-12-28 00:00:00

  • Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant Progression.

    abstract::Consequences of the obesity epidemic on cancer morbidity and mortality are not fully appreciated. Obesity is a risk factor for many cancers, but the mechanisms by which it contributes to cancer development and patient outcome have yet to be fully elucidated. Here, we examined the effects of coculturing human-derived a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-0927

    authors: Picon-Ruiz M,Pan C,Drews-Elger K,Jang K,Besser AH,Zhao D,Morata-Tarifa C,Kim M,Ince TA,Azzam DJ,Wander SA,Wang B,Ergonul B,Datar RH,Cote RJ,Howard GA,El-Ashry D,Torné-Poyatos P,Marchal JA,Slingerland JM

    更新日期:2016-01-15 00:00:00

  • The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinase.

    abstract::Cells with a temperature-sensitive mutant of the v-abl oncoprotein (IC.DP) were treated with the anticancer drugs melphalan or hydroxyurea. At the restrictive temperature for v-ABL protein tyrosine kinase activity, drug-treated IC.DP cells died by apoptosis. In contrast, apoptotic cell death induced by either drug was...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chapman RS,Whetton AD,Dive C

    更新日期:1994-10-01 00:00:00

  • Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex.

    abstract::Most squamous cell carcinomas of the head and neck (HNSCC) overexpress ERBB1/EGFR, but EGF receptor (EGFR)-targeted therapies have yielded disappointing clinical results in treatment of this cancer. Here, we describe a novel interaction between EGFR and the ligand EphrinB1 (EFNB1), and we show that EFNB1 phosphorylati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0760

    authors: Vermeer PD,Colbert PL,Wieking BG,Vermeer DW,Lee JH

    更新日期:2013-09-15 00:00:00

  • Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.

    abstract::Arzoxifene ([6-hydroxy-3-[4-[2-(1-piperidinyl)-ethoxy]phenoxy]-2-(4-methoxyphenyl)]benzo[b]thiophene) is a selective estrogen receptor modulator (SERM) that is a potent estrogen antagonist in mammary and uterine tissue while acting as an estrogen agonist to maintain bone density and lower serum cholesterol. Arzoxifene...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Suh N,Glasebrook AL,Palkowitz AD,Bryant HU,Burris LL,Starling JJ,Pearce HL,Williams C,Peer C,Wang Y,Sporn MB

    更新日期:2001-12-01 00:00:00

  • Metastasizing neuroblastomas in mice transgenic for simian virus 40 large T (SV40T) under the olfactory marker protein gene promoter.

    abstract::The olfactory marker protein (OMP) is a M(r) 19,000 polypeptide originally considered a selective marker for differentiated olfactory receptor neurons. In an attempt to induce neoplastic proliferation in the olfactory cells, we made mice transgenic for the simian virus 40 large T-antigen gene linked to the OMP gene pr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Servenius B,Vernachio J,Price J,Andersson LC,Peterson PA

    更新日期:1994-10-01 00:00:00

  • ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors.

    abstract::The BCR-ABL oncogene is responsible for most cases of chronic myelogenous leukemia and some acute lymphoblastic leukemias. The fusion protein encoded by BCR-ABL possesses an aberrantly regulated tyrosine kinase activity. Imatinib mesylate (Gleevec, STI-571) is an inhibitor of ABL tyrosine kinase activity that has been...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-04-3888

    authors: Kharas MG,Fruman DA

    更新日期:2005-03-15 00:00:00

  • False-positive and false-negative rates for carcinogenicity screens.

    abstract::The implementation of a number of chemical carcinogen screening programs has been accompanied by the observation that some screens might have high false-positive error rates. With designs presently used at the National Cancer Institute and historical spontaneous tumor rates based upon control animals in previous exper...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fears TR,Tarone RE,Chu KC

    更新日期:1977-07-01 00:00:00

  • A new in vivo model to study invasion and metastasis of human bladder carcinoma.

    abstract::An animal model to investigate the invasive and metastatic properties of human bladder transitional cell carcinoma (HTCC) was established. Two long-term HTCC cell lines (RT4 and EJ) and one HTCC cell line derived in our laboratory (LD-71) were tumorigenic when injected s.c. into nude mice but had little potential to i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ahlering TE,Dubeau L,Jones PA

    更新日期:1987-12-15 00:00:00

  • The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.

    abstract::The gene of phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) has been implicated as an oncogene in ovarian cancer [L. Shayesteh et al., Nat. Genet., 21: 99-102, 1999]. In this study, we examined the expression of PIK3CA mRNA and its p110alpha protein product in human ovarian carcinoma and investigated it...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zhang L,Yang N,Katsaros D,Huang W,Park JW,Fracchioli S,Vezzani C,Rigault de la Longrais IA,Yao W,Rubin SC,Coukos G

    更新日期:2003-07-15 00:00:00

  • DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

    abstract::Hypomethylation of CpG dinucleotides in genomic DNA was one of the first somatic epigenetic alterations discovered in human cancers. DNA hypomethylation is postulated to occur very early in almost all human cancers, perhaps facilitating genetic instability and cancer initiation and progression. We therefore examined t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6088

    authors: Yegnasubramanian S,Haffner MC,Zhang Y,Gurel B,Cornish TC,Wu Z,Irizarry RA,Morgan J,Hicks J,DeWeese TL,Isaacs WB,Bova GS,De Marzo AM,Nelson WG

    更新日期:2008-11-01 00:00:00

  • Investigation of hormone-receptor interactions by means of fluorescence labeling.

    abstract::Fluorescent-labeled hormones can be used to study hormone-receptor interactions by means of fluorescence polarization, visualization by fluorescence microscopy, or separation methods, e.g., dextran-coated charcoal. Subcellular fragments, single cells, and tissue preparations are amenable to study; in this work rat ute...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dandliker WB,Brawn RJ,Hsu ML,Brawn PN,Levin J,Meyers CY,Kolb VM

    更新日期:1978-11-01 00:00:00

  • Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.

    abstract::Paclitaxel (Taxol) is a chemotherapeutic agent that prevents disassembly of microtubular polymers, causing a growth arrest in the G2-M phase of the cell cycle and leading to apoptotic death. Paclitaxel has remarkable efficacy against fast-growing tumors but possesses major drawbacks, such as poor solubility and lack o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Guillemard V,Saragovi HU

    更新日期:2001-01-15 00:00:00

  • Comparison of the malignant potential of 10T 1/2 cells and transformants with their survival responses to hyperthermia and to amphotericin B1.

    abstract::Several responses of 10T 1/2 cells and of cells from strains transformed by X-irradiation or by methylcholanthrene exposure were examined. Malignant potential, as determined by the ability of the cells to initiate tumors in syngeneic hosts, either normal or rendered immunodeficient, varied by a factor of 10(6). The gr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hahn GM

    更新日期:1980-10-01 00:00:00

  • Flow cytometric detection of drugs altering the DNA methylation pattern.

    abstract::We have developed a model system for assessing the demethylating potential of external agents. Disruption in the DNA methylation pattern was evaluated at the translational level of the Escherichia coli beta-galactosidase coding gene (lacZ). We have constructed a clonal cell line (A4/4 cells) derived from the adenoviru...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Biard DS,Maratrat M,Thybaud V,Melcion C,Sarasin A

    更新日期:1992-10-01 00:00:00

  • Alteration in binding of dexamethasone to glucocorticoid receptors in regenerating rat liver after partial hepatectomy.

    abstract::Changes in binding of dexamethasone (9 alpha-fluoro-11 beta, 17 alpha, 21-trihydroxy-16 alpha-methylpregna-1,4-diene-3,20-dione) to its receptors in regenerating rat liver after 70% hepatectomy were examined. Specific receptors for dexamethasone in the liver remnants of adrenalectomized rats decreased significantly du...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Isohashi F,Tsukanaka K,Terada M,Nakanishi Y,Fukushima H,Sakamoto Y

    更新日期:1979-12-01 00:00:00

  • Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery.

    abstract::We studied the conditions required for eradication by immunization of occult lymph node metastases which remained after surgical removal of an intradermally transplanted cavian hepatoma. Guinea pigs that received no postsurgical treatment all died with progressively growing lymph node metastases. The growth of these m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ashley MP,Zbar B,Hunter JT,Rapp HJ,Sugimoto T

    更新日期:1980-11-01 00:00:00

  • Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.

    abstract::Cisplatin (cis-diamminedichloroplatinum, CDDP) is one of the most used drugs for osteosarcoma chemotherapy. By using a series of CDDP-resistant variants, which were established from the U-2OS and Saos-2 human osteosarcoma cell lines, we found that CDDP resistance was mainly associated with the increase of both the int...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5840

    authors: Pasello M,Michelacci F,Scionti I,Hattinger CM,Zuntini M,Caccuri AM,Scotlandi K,Picci P,Serra M

    更新日期:2008-08-15 00:00:00